What's in St. Joseph's Healthcare Hamilton's pipeline?

St. Joseph's Healthcare Hamilton has 11 drugs in our index: 8 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with St. Joseph's Healthcare Hamilton's portfolio?

Top competitors by shared drug class: Ahmed M Maged, MD, Amsterdam UMC, location VUmc, Azienda Policlinico Umberto I, Bayer, Benaroya Research Institute.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/st-joseph-s-healthcare-hamilton.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

St. Joseph's Healthcare Hamilton — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

St. Joseph's Healthcare Hamilton pipeline: 8 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

8 marketed 0 filed 0 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
fluticasone 25, 50, 100, 200 mcg	fluticasone 25, 50, 100, 200 mcg	marketed
Bisacodyl 10mg	Bisacodyl 10mg	marketed
Phytonadione (Vitamin K1)	Phytonadione (Vitamin K1)	marketed	Vitamin K1 / Cofactor	Gamma-glutamyl carboxylase	Hematology / Anticoagulation
Ketorolac 0.5% Eye Drops	Ketorolac 0.5% Eye Drops	marketed
Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops	Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops	marketed
Polyethelene Glycol	Polyethelene Glycol	marketed	Osmotic laxative		Gastroenterology
Antibiotics	Antibiotics	marketed			Infectious Disease
Picosulfate sodium	Picosulfate sodium	marketed	Stimulant laxative	Myenteric plexus / colonic smooth muscle	Gastroenterology

Therapeutic area mix

Gastroenterology · 2
Hematology / Anticoagulation · 1
Infectious Disease · 1
Nutrition · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ahmed M Maged, MD · 1 shared drug class
Amsterdam UMC, location VUmc · 1 shared drug class
Azienda Policlinico Umberto I · 1 shared drug class
Bayer · 1 shared drug class
Benaroya Research Institute · 1 shared drug class
Bo-In Lee · 1 shared drug class
Braintree Laboratories · 1 shared drug class
Aboca Spa Societa' Agricola · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for St. Joseph's Healthcare Hamilton:

Cite this brief

Drug Landscape (2026). St. Joseph's Healthcare Hamilton — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/st-joseph-s-healthcare-hamilton. Accessed 2026-05-17.